Suubi+Adherence study protocol: A family economic empowerment intervention addressing HIV treatment adherence for perinatally infected adolescents

Fred M Ssewamala, William Byansi, Ozge Sensoy Bahar, Proscovia Nabunya, Torsten B Neilands, Claude Mellins, Mary McKay, Flavia Namuwonge, Miriam Mukasa, Fredrick Edward Makumbi, Gertrude Nakigozi, Fred M Ssewamala, William Byansi, Ozge Sensoy Bahar, Proscovia Nabunya, Torsten B Neilands, Claude Mellins, Mary McKay, Flavia Namuwonge, Miriam Mukasa, Fredrick Edward Makumbi, Gertrude Nakigozi

Abstract

Background: Globally, 1.8 million children<15 years are living with HIV. Sub-Saharan Africa (SSA), as a region, is heavily burdened by HIV, with 90% of new infections among children happening there. Within SSA, Uganda has an HIV prevalence of 7.2% among 15-49-year-olds, with high prevalence in Masaka region (12%). Uganda also reports unprecedented numbers of perinatally HIV-infected children, with close to 150,000 children (ages 0-14) living with HIV (CLHA). However adherence to antiretroviral therapy (ART) among children and youth is poor, and has been attributed to economic insecurity, including lack of finances for transportation to clinic appointments, inadequate meals to support medication consumption, and resource prioritization towards school expenses. Yet, few programs aimed at addressing ART adherence have applied combination interventions to address economic stability and ART Adherence within the traditional framework of health education and HIV care. This paper describes a study protocol for a 5-year, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) funded, cluster randomized-controlled trial to evaluate a combination intervention, titled Suubi + Adherence, aimed at improving ART adherence among HIV perinatally infected adolescents (ages 10-16 at study enrollment) in Uganda.

Methods: Suubi + Adherence was evaluated via a two-arm cluster randomized-controlled trial design in 39 health clinics, with a total enrollment of 702 HIV + adolescents (ages 10-16 at enrollment). The study addresses two primary outcomes: 1) adherence to HIV treatment regimen and 2) HIV knowledge and attitudes. Secondary outcomes include family functioning, sexual risk-taking behavior, and financial savings behavior. For potential scale-up, cost effectiveness analysis was employed to compare the relative costs and outcomes associated with each study arm: family economic strengthening comprising matched savings accounts, financial management training and small business development, all intended for family economic security versus bolstered usual care (SOC) comprising enhanced adherence sessions to ensure more standardized and sufficient adherence counseling.

Discussion: This study aims to advance knowledge and inform the development of the next generation of programs aimed at increasing adherence to HIV treatment for HIV + adolescents in low-resource regions such as SSA. To our knowledge, the proposed study is the first to integrate and test family economic empowerment and stability-focused interventions for HIV + adolescents in Uganda (and much of SSA)-so families would have the necessary finances to manage HIV/AIDS as a chronic illness. The study would provide crucial evidence about the effects of an economic empowerment program on short and long-term impact, which is essential if such interventions are to be taken to scale.

Trial registration: This trial was registered with ClinicalTrials.gov (registration number: NCT01790373) on 13 February 2013.

Keywords: Adherence to HIV antiretroviral therapy; Adolescents; Economic empowerment interventions; HIV perinatal infection; Poverty; Suubi.

© 2019 The Author(s).

Figures

Fig. 1
Fig. 1
Suubi+Adherence Study Design
Fig. 2
Fig. 2
Suubi+Adherence time frame
Fig. 3
Fig. 3
CONSORT Flow Diagram – Suubi+Adherence

References

    1. UNAIDS Children and HIV: fact sheet. Accessed 10 June 2018.
    1. Joint United Nations Programme on HIV/AIDS Global report 2012: UNAIDS report on the global AIDS epidemic. UN. 2012. Accessed 12 June 2018.
    1. UNAIDS Gap report. 2014. Accessed 12 June 2018.
    1. HIV and AIDS Uganda country progress report. Retrieved from. Accessed 10 June 2018.
    1. Joint United Nations Programme on HIV/AIDS UNAIDS data 2017. 2017. Available at. Accessed 12 June 2018.
    1. UNAIDS On the fast-track to an AIDS-free generation. 2016. Retrieved from. Accessed 10 June 2018.
    1. Turan J.M., Nyblade L. HIV-related stigma as a barrier to achievement of global PMTCT and maternal health goals: a review of the evidence. AIDS Behav. 2013 Sep 1;17(7):2528–2539.
    1. Varga C.A., Sherman G.G., Jones S.A. HIV-disclosure in the context of vertical transmission: HIV-positive mothers in Johannesburg, South Africa. AIDS Care. 2006 Nov 1;18(8):952–960.
    1. Eide M., Myhre M., Lindbæk M., Sundby J., Arimi P., Thior I. Social consequences of HIV-positive women's participation in prevention of mother-to-child transmission programmes. Patient Educ. Couns. 2006 Feb 1;60(2):146–151.
    1. Kebaabetswe P.M. Barriers to participation in the prevention of mother-to-child HIV transmission program in Gaborone, Botswana a qualitative approach. AIDS Care. 2007 Mar 1;19(3):355–360.
    1. Bond V., Chase E., Aggleton P. Stigma, HIV/AIDS and prevention of mother-to-child transmission in Zambia. Eval. Program Plann. 2002 Nov 1;25(4):347–356.
    1. Gourlay A., Birdthistle I., Mburu G., Iorpenda K., Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother‐to‐child transmission of HIV in sub‐Saharan Africa: a systematic review. J. Int. AIDS Soc. 2013 Jan;16(1):18588.
    1. Domek G.J. Social consequences of antiretroviral therapy: preparing for the unexpected futures of HIV-positive children. Lancet Lond Engl. 2006 Apr 22;367(9519):1367–1369.
    1. Malee K.M., Tassiopoulos K., Huo Y., Siberry G., Williams P.L., Hazra R. Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure. AIDS Care. 2011 Dec;23(12):1533–1544.
    1. Mellins C.A., Tassiopoulos K., Malee K., Moscicki A.-B., Patton D., Smith R. Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS. 2011 Jul;25(7):413–422.
    1. Bangsberg D.R., Perry S., Charlebois E.D., Clark R.A., Roberston M., Zolopa A.R. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS Lond Engl. 2001 Jun 15;15(9):1181–1183.
    1. Gifford A.L., Bormann J.E., Shively M.J., Wright B.C., Richman D.D., Bozzette S.A. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J. Acquir. Immune Defic. Syndr. 1999;23(5):386–395. 2000 Apr 15.
    1. Hogg R.S., Heath K., Bangsberg D., Yip B., Press N., O'Shaughnessy M.V. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS Lond Engl. 2002 May 3;16(7):1051–1058.
    1. Hogg R., Yip B., Chan K., O'Shaughnessy M., Montaner J. 13th International AIDS Conference. 2000. July). Non-adherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women. (Durban, South Africa)
    1. Johnson M.O., Catz S.L., Remien R.H., Rotheram-Borus M.J., Morin S.F., Charlebois E. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care STDS. 2003 Dec;17(12):645–656.
    1. Paterson D.L., Swindells S., Mohr J., Brester M., Vergis E.N., Squier C. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann. Intern. Med. 2000 Jul 4;133(1):21–30.
    1. Wood E., Hogg R.S., Yip B., Harrigan P.R., O'Shaughnessy M.V., Montaner J.S.G. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann. Intern. Med. 2003 Nov 18;139(10):810–816.
    1. Vanhove G.F., Schapiro J.M., Winters M.A., Merigan T.C., Blaschke T.F. Patient compliance and drug failure in protease inhibitor monotherapy. J. Am. Med. Assoc. 1996 Dec 25;276(24):1955–1956.
    1. Mills E.J., Nachega J.B., Buchan I., Orbinski J., Attaran A., Singh S. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. J. Am. Med. Assoc. 2006 Aug 9;296(6):679–690.
    1. Cambiano V., Lampe F.C., Rodger A.J., Smith C.J., Geretti A.M., Lodwick R.K. Long-term trends in adherence to antiretroviral therapy from start of HAART. AIDS Lond Engl. 2010 May 15;24(8):1153–1162.
    1. Blower S.M., Aschenbach A.N., Gershengorn H.B., Kahn J.O. Predicting the unpredictable: transmission of drug-resistant HIV. Nat. Med. 2001 Sep;7(9):1016–1020.
    1. Peltzer K., Pengpid S. Socioeconomic factors in adherence to HIV therapy in low- and middle-income countries. J. Health Popul. Nutr. 2013 Jun;31(2):150–170.
    1. Center for Disease Control and Prevention . 2013, April 15. Initiation of and Adherence to Treatment as Prevention. Retrieved October 28, 2014.
    1. Nachega J., Hislop M., Nguyen H., Dowdy D., E Chaisson R., Regensberg L. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J. Acquir. Immune Defic. Syndr. 1999;51:65–71. 2009 Mar 1.
    1. Denison J.A., Banda H., Dennis A.C., Packer C., Nyambe N., Stalter R.M. “The sky is the limit”: adhering to antiretroviral therapy and HIV self-management from the perspectives of adolescents living with HIV and their adult caregivers. J. Int. AIDS Soc. 2015;18:19358.
    1. Ammon N., Mason S., Corkery J.M. Factors impacting antiretroviral therapy adherence among human immunodeficiency virus-positive adolescents in Sub-Saharan Africa: a systematic review. Public Health. 2018 Apr;157:20–31.
    1. Mutumba Massy. Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV. AIDS Care. 2016;28(7):807–815.
    1. Kim Maria H. High self‐reported non‐adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors. J. Int. AIDS Soc. 2017;20(1):21437.
    1. Galea Jerome T. Barriers and facilitators to antiretroviral therapy adherence among Peruvian adolescents living with HIV: a qualitative study. PLoS One. 2018;13(2)
    1. Williams B.G., Granich R., Cock K.M.D., Glaziou P., Sharma A., Dye C. Antiretroviral therapy for tuberculosis control in nine African countries. Proc. Natl. Acad. Sci. 2010 Nov 9;107(45)
    1. Marais B.J., Esser M., Godwin S., Rabie H., Cotton M.F. Poverty and human immunodeficiency virus in children. Ann. N. Y. Acad. Sci. 2008 Jun 1;1136(1)
    1. Tuller D.M., Bangsberg D.R., Senkungu J., Ware N.C., Emenyonu N., Weiser S.D. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010 Aug;14(4):778–784.
    1. Hardon A.P., Akurut D., Comoro C., Ekezie C., Irunde H.F., Gerrits T. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007 May;19(5):658–665.
    1. Weiser S., Wolfe W., Bangsberg D., Thior I., Gilbert P., Makhema J. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J. Acquir. Immune Defic. Syndr. 1999;34(3):281–288. 2003 Nov 1.
    1. Nabukeera-Barungi N., Elyanu P., Asire B., Katureebe C., Lukabwe I., Namusoke E., Musinguzi J., Atuyambe L., Tumwesigye N. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda. BMC Infect. Dis. 2015 Dec;15(1):520.
    1. Gusdal A.K., Obua C., Andualem T., Wahlstrom R., Tomson G., Peterson S. Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option? AIDS Care. 2009 Nov;21(11):1381–1387.
    1. Ramadhani H.O., Thielman N.M., Landman K.Z., Ndosi E.M., Gao F., Kirchherr J.L. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007 Dec 1;45(11):1492–1498.
    1. Piot P., Greener R., Russell S. Squaring the circle: AIDS, poverty, and human development. PLoS Med. 2007 Oct 23;4(10):e314.
    1. Biadgilign S., Deribew A., Amberbir A., Deribe K. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: a qualitative study. SAHARA-J J Soc Asp HIVAIDS [Internet] 2009 Jan 1;6(4)
    1. Haberer J.E., Kiwanuka J., Nansera D., Wilson I.B., Bangsberg D.R. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010 Dec;14(6):1294–1301.
    1. Li R.J., Jaspan H.B., O'Brien V., Rabie H., Cotton M.F., Nattrass N. Positive futures: a qualitative study on the needs of adolescents on antiretroviral therapy in South Africa. AIDS Care. 2010 Jun;22(6):751–758.
    1. Au J.T., Kayitenkore K., Shutes E., Karita E., Peters P.J., Tichacek A. Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. AIDS Lond Engl. 2006 Oct 24;20(16):2116–2118.
    1. Haberer J., Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr. HIV AIDS Rep. 2009 Nov;6(4):194–200.
    1. Simoni J.M., Amico K.R., Pearson C.R., Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr. Infect. Dis. Rep. 2008 Nov;10(6):515–521.
    1. Sherraden M. M.E. Sharpe; New York: 1991. Assets and the Poor: A New American Welfare Policy. [Internet]
    1. Ssewamala F.M., Ismayilova L. Integrating children's savings accounts in the care and support of orphaned adolescents in rural Uganda. Soc. Serv. Rev. 2009 Sep 1;83(3):453–472.
    1. Ssewamala F.M., Sherraden M. Integrating saving into microenterprise programs for the poor: do institutions matter? Soc. Serv. Rev. 2004 Sep 1;78(3):404–428.
    1. Ssewamala F.M., Ismayilova L., McKay M., Sperber E., Bannon W., Alicea S. Gender and the effects of an economic empowerment program on attitudes toward sexual risk-taking among AIDS-orphaned adolescent youth in Uganda. J Adolesc Health Off Publ Soc Adolesc Med. 2010 Apr;46(4):372–378.
    1. National Antiretroviral Treatment Guidelines for Adults Adolescents, and children | knowledge management portal. Accessed 12 August 2018.
    1. Petersen I., Mason A., Bhana A., Bell C.C., Mckay M. Mediating social representations using a cartoon narrative in the context of HIV/AIDS the AmaQhawe family project in South Africa. J. Health Psychol. 2006 Mar;11(2):197–208.
    1. Bhana A., Petersen I., Mason A., Mahintsho Z., Bell C., McKay M. Children and youth at risk: adaptation and pilot study of the CHAMP (Amaqhawe) programme in South Africa. Afr. J. AIDS Res. 2004 May 1;3(1):33–41.
    1. McKay M.M., Chasse K.T., Paikoff R., McKinney L.D., Baptiste D., Coleman D., Madison S., Bell C.C. Family‐level impact of the CHAMP Family Program: a community collaborative effort to support urban families and reduce youth HIV risk exposure. Fam. Process. 2004 Mar;43(1):79–93.
    1. Bhana A., McKay M.M., Mellins C., Petersen I., Bell C. Family-based HIV prevention and intervention services for youth living in poverty-affected contexts: the CHAMP model of collaborative, evidence-informed programme development. J. Int. AIDS Soc. 2010 Dec;13(2):S8.
    1. Hayes R.J., Moulton L.H. Chapman and Hall/CRC; 2017 Jul 6. Cluster Randomised Trials.
    1. Diggle P., Heagerty P., Liang K.-Y., Zeger S. Oxford University Press.; Oxford: 2002. Analysis of Longitudinal Data.
    1. Cohen J. second ed. Lawrence Erlbaum Associates, Inc.; Hillsdale, NJ: 1987. Statistical Power Analysis for the Behavioral Sciences.
    1. Fitts W.H., Warren W.L. Western Psychological Services; Los Angeles: 1996. Tennessee Self-Concept Scale: TSCS-2.
    1. Vaux A., Riedel S., Stewart D. Modes of social support: the social support behaviors (SS‐B) scale. Am. J. Community Psychol. 1987 Apr;15(2):209–232.
    1. Krauss B.J. HIV Infection in Women Conference. 1995. Calm down, Mom, let's talk about sex, drugs and HIV: 10–13 year old girls' prescriptions for HIV prevention conversations in their high HIV seroprevalence neighborhood. Feb 22.
    1. Gerard A.B. Western psychological services; Los Angeles: 1994. Parent-child Relationship Inventory.
    1. Beck A.T., Weissman A., Lester D., Trexler L. The measurement of pessimism: the hopelessness scale. J. Consult. Clin. Psychol. 1974 Dec;42(6)
    1. Ssewamala F. Washington University, St. Louis: Center for Social Development; 2004. Saving for Microenterprise in Individual Development Accounts: Lessons from the American Dream Demonstration.
    1. Levy S.R., Lampman C., Handler A., Flay B.R., Weeks K. AIDS Education and Prevention; 1993. Young Adolescent Attitudes toward Sex and Substance Use: Implications for AIDS Prevention.
    1. Paikoff R.L. Early heterosexual debut: situations of sexual possibility during the transition to adolescence. Am. J. Orthopsychiatry. 1995 Jul;65(3)
    1. Auslander W.F., Slonim-Nevo V., Ozawa M., Shepard S., Gehlert S. VIII International Conference on AIDS/III STD World Congress. July 1992. Comparison of skills training, discussion, and control groups to prevent AIDS among abused and delinquent youth. Amsterdam, The Netherlands.
    1. Slonim-Nevo V., Auslander W.F., Ozawa M.N. Educational options and AIDS-related behaviors among troubled adolescents. J. Pediatr. Psychol. 1995 Feb 1;20(1):41–60.
    1. Kovacs M. Multi-Health Systems; North Tonawanda, NY: 1992. Children's Depression Inventory.
    1. Little R.J.A., Rubin D.B. second ed. John Wiley and Sons; New York: 2002. Statistical Analysis with Missing Data.
    1. Longford N.T. Oxford Statistical Science Series; 1993. Random Coefficient Models.
    1. Westfall P.H., Young S.S. John Wiley and Sons; New York, NY: 1993. Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment.
    1. Kenny D.A., Calsyn R.J., Morse G.A., Klinkenberg W.D., Winter J.P., Trusty M.L. Evaluation of treatment programs for persons with severe mental illness: moderator and mediator effects. Eval. Rev. 2004 Aug;28(4):294–324.
    1. Singer J.D. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J. Educ. Behav. Stat. 1998;23(4):323–355.
    1. Geert M., Geert V. Springer; New York: 2005. Models for Discrete Longitudinal Data.
    1. Fitzmaurice G.M., Laird N.M., Ware J.H. Wiley & Sons; John Hoboken, NJ: 2004. Applied Longitudinal Analysis.
    1. Cook R.D., Weisberg S. Chapman and Hall.; New York: 1982. Residuals and Influence in Regression.
    1. Fox J. Sage Publications, Inc.; Iowa City: 1991. Regression Diagnostics: an Introduction.
    1. Gramlich E.M. second ed. Waveland Press, Inc; Long Grove, IL: 1997. A Guide to Benefit-Cost Analysis.
    1. Boardman A., Greenberg D., Vining A. third ed. Prentice Hall; Upper Saddle River, NJ: 2005. Cost Benefit Analysis: Concepts and Practice.
    1. Zarkin G.A., Bala M.V., Wood L.L., Bennett C.L., Simpson K., Dohn M.N. Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia. PharmacoEconomics. 1996 Jun 1;9(6):525–534.
    1. Zarkin G.A., Bala M.V., Calingaert B., VanderLugt J.T. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm. Am. J. Manag. Care. 1997 Sep;3(9):1387–1394.
    1. Doubilet P., McNeil B.J. Clinical decision making. Med. Care. 1985;23(5):648–662.
    1. Manning W.G., Fryback D.G., Weinstein M.C. Reflecting uncertainty in cost effectiveness analyses. In: Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C., editors. Cost-effectiveness in Health and Medicine. Oxford University Press; New York: 1996. pp. 247–275.
    1. Evans D., Kremer M.R., Ngatia M. Poverty Action Lab Publications; Cambridge, MA: 2009. The Impact of Distributing School Uniforms on Children's Education in Kenya.
    1. Simoni J.M., Amico K.R., Smith L., Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr. HIV AIDS Rep. 2010 Feb;7(1):44–51.
    1. Simoni J.M., Pearson C.R., Pantalone D.W., Marks G., Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J. Acquir. Immune Defic. Syndr. 1999;43(Suppl 1):S23–S35. 2006 Dec 1.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj